TELZIR

This brand name is authorized in Australia, Austria, Brazil, Canada, Croatia, Cyprus, Estonia, Finland, France, Ireland, Italy, Lithuania, Netherlands, Poland, Romania, South Africa, Spain, Turkey, UK.

Active ingredients

The drug TELZIR contains one active pharmaceutical ingredient (API):

1	Fosamprenavir UNII ID1GU2627N - FOSAMPRENAVIR CALCIUM
	Fosamprenavir after oral administration, is rapidly and almost completely hydrolysed to amprenavir and inorganic phosphate prior to reaching the systemic circulation. Amprenavir binds to the active site of HIV-1 protease and thereby prevents the processing of viral gag and gag-pol polyprotein precursors, resulting in the formation of immature noninfectious viral particles.
	Read more about Fosamprenavir

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
TELZIR Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J05AE07	Fosamprenavir	J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AE Protease inhibitors
Discover more medicines within J05AE07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10337C
BR	Câmara de Regulação do Mercado de Medicamentos	510610601112219, 510614060051805
CA	Health Products and Food Branch	02261545, 02261553
EE	Ravimiamet	1204782, 1204793
ES	Centro de información online de medicamentos de la AEMPS	04282001, 04282002
FI	Lääkealan turvallisuus- ja kehittämiskeskus	091016
FR	Base de données publique des médicaments	61312477, 63544054
GB	Medicines & Healthcare Products Regulatory Agency	79636
IT	Agenzia del Farmaco	036475010, 036475022
LT	Valstybinė vaistų kontrolės tarnyba	1031081, 1031082
NL	Z-Index G-Standaard, PRK	76007
PL	Rejestru Produktów Leczniczych	100092192, 100092772
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W65021001
TR	İlaç ve Tıbbi Cihaz Kurumu	8699522096268
ZA	Health Products Regulatory Authority	A38/20.2.8/0378, A38/20.2.8/0379